Description
Cabozantinib 20mg is an oral, targeted anti-cancer medication (Tyrosine Kinase Inhibitor). It treats advanced cancers (such as renal cell carcinoma and medullary thyroid carcinoma) by blocking proteins that fuel tumor growth and new blood vessel formation. The 20mg strength is often used for dose adjustments or combined with other strengths. [1, 2, 3]
Key Characteristics
- Active Ingredient: Each film-coated tablet contains cabozantinib (S)-malate equivalent to 20 mg cabozantinib. [1]
- Primary Indications: Advanced renal cell carcinoma (kidney cancer), hepatocellular carcinoma (liver cancer), and medullary thyroid cancer

Reviews
There are no reviews yet.